Please use this identifier to cite or link to this item:
Title: The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates
Authors: Buhigas, C
Warren, AY
Leung, WK
Whitaker, HC
Luxton, HJ
Hawkins, S
Kay, J
Butler, A
Xu, Y
Woodcock, DJ
Merson, S
Frame, FM
Sahli, A
Abascal, F
Gihawi, A
Lambert, A
Thompson, A
Futreal, A
Menzies, A
Baddage, A
Ng, A
Sahil, A
Kremeyer, B
Al-Lazikani, B
Massie, C
Greenman, C
Ogden, C
Verrill, C
Fisher, C
Berney, D
Burns, D
Leongamornlert, D
Jones, D
Nicol, D
Wedge, D
Cahill, D
Easton, D
Rowe, E
Riabchenko, E
Bancroft, E
Mayer, E
Anokian, E
Hamdy, F
Park, G
Pelvender, G
Leeman, G
Gundem, G
Zhang, H
Mills, IG
Zhang, J
Teague, J
Zamora, J
Karaszi, K
Raine, K
Matthews, L
Stebbings, L
Alexandrov, LB
Marsden, L
Ahmed, M
Nykter, M
Ghori, M
Livni, N
Dennis, N
Van As, N
Camacho, N
Shah, N
Kumar, P
Van Loo, P
Lach, R
Edwards, S
Pita, S
Field, SJ
Thomas, S
Tavaré, S
Scalabrino, S
Hazell, S
McLaren, S
Visakorpi, T
Mitchell, TJ
Dudderidge, T
Dadaev, T
McDermott, U
Bo, V
Haberland, V
Gnanapragasam, V
Khoo, V
Howat, W
Jie-Lu, Y
Yu, Y
Kote-Jarai, Z
Martincorena, I
Bova, GS
Foster, CS
Campbell, P
Maitland, NJ
Neal, DE
Massie, CE
Lynch, AG
Eeles, RA
Cooper, CS
Keywords: prostate cancer;clonal expansions;genomics;normal tissue;benign prostatic hyperplasia;field effect;mutational signatures
Issue Date: 22-Sep-2022
Publisher: BioMed Central (Springer Nature)
Citation: Buhigas, C., CRUK-ICGC Prostate Cancer Group et al. (2022) 'The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates', Molecular Cancer, 21 (1), 183, pp. 1 - 13. doi: 10.1186/s12943-022-01644-3.
Abstract: Copyright © The Author(s) 2022. Background Up to 80% of cases of prostate cancer present with multifocal independent tumour lesions leading to the concept of a field effect present in the normal prostate predisposing to cancer development. In the present study we applied Whole Genome DNA Sequencing (WGS) to a group of morphologically normal tissue (n = 51), including benign prostatic hyperplasia (BPH) and non-BPH samples, from men with and men without prostate cancer. We assess whether the observed genetic changes in morphologically normal tissue are linked to the development of cancer in the prostate. Results Single nucleotide variants (P = 7.0 × 10–03, Wilcoxon rank sum test) and small insertions and deletions (indels, P = 8.7 × 10–06) were significantly higher in morphologically normal samples, including BPH, from men with prostate cancer compared to those without. The presence of subclonal expansions under selective pressure, supported by a high level of mutations, were significantly associated with samples from men with prostate cancer (P = 0.035, Fisher exact test). The clonal cell fraction of normal clones was always higher than the proportion of the prostate estimated as epithelial (P = 5.94 × 10–05, paired Wilcoxon signed rank test) which, along with analysis of primary fibroblasts prepared from BPH specimens, suggests a stromal origin. Constructed phylogenies revealed lineages associated with benign tissue that were completely distinct from adjacent tumour clones, but a common lineage between BPH and non-BPH morphologically normal tissues was often observed. Compared to tumours, normal samples have significantly less single nucleotide variants (P = 3.72 × 10–09, paired Wilcoxon signed rank test), have very few rearrangements and a complete lack of copy number alterations. Conclusions Cells within regions of morphologically normal tissue (both BPH and non-BPH) can expand under selective pressure by mechanisms that are distinct from those occurring in adjacent cancer, but that are allied to the presence of cancer. Expansions, which are probably stromal in origin, are characterised by lack of recurrent driver mutations, by almost complete absence of structural variants/copy number alterations, and mutational processes similar to malignant tissue. Our findings have implications for treatment (focal therapy) and early detection approaches.
Description: Availability of data and materials: The datasets generated during the current study are available in the European Genome-Phenome Archive repository, and The variant calls generated are available from the corresponding author on reasonable request.
Supplementary information is available online at .
Other Identifiers: ORCID iDs: Valeriia Haberland
Appears in Collections:Dept of Computer Science Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © The Author(s) 2022. Rights and permissions: Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.1.85 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons